Antipsychotics and Metabolic Syndrome
Suspended
- Conditions
- Metabolic Syndrome
- Registration Number
- NCT00636753
- Lead Sponsor
- Glostrup University Hospital, Copenhagen
- Brief Summary
The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
- Gender male
- Age 18-45
- Debut drug-naive schizophrenics,
- Caucasians
- Consent given to take part in the project
Exclusion Criteria
- Compliance-problems
- Major lung-/kidney/hart/lever disorders
- Abuse of alcohol/drugs
- Diabetes 1 and 2
- Antihypertensive
- Anticholesterol-reducing medication
- Patients under duress
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Psychiatric Center Glostrup
🇩🇰Nordre Ringvej 28-69, Glostrup, Denmark